RVMDRevolution Medicines, Inc.

$189.76+336% 1Y

Is the price fair?

What RVMD's price assumes

Price / book
14.4

Price / book · as of 2026-Q2

Details›
Price / bookas of 2026-Q2
14.4
Market capitalisation
$37.9B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.